检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:熊良庚[1] 柏茂树[1] 刘继明[1] 梁百武 武红梅[1]
出 处:《中医临床研究》2014年第16期17-18,共2页Clinical Journal Of Chinese Medicine
摘 要:目的:探讨沙参麦冬汤合桑菊饮对晚期非小细胞肺癌(NSCLC)同步放化疗所致不良反应的影响。方法:将72例晚期NSCLC患者随机分成对照组(n=36)和观察组(n=36),对照组采用单纯同步放化疗治疗,观察组联合给予沙参麦冬汤合桑菊饮治疗,观察记录两组NSCLC患者的不良反应。结果:两组患者在胃肠道反应和白细胞减少方面比较差异有统计学意义(P<0.05),而在肝功能损害(谷丙转氨酶升高)方面差异无统计学意义(P>0.05)。结论:沙参麦冬汤合桑菊饮可明显减少或减轻晚期NSCLC同步放化疗患者的不良反应,提高患者对放化疗的耐受性。Objective: To observe the influence of adverse reactions results from treating advanced non-small cell lung cancer chemo radiotherapy with Shashen Maidong decoction plus Sangju Yin. Methods:72 patients were randomly divided into two groups, 36 cases for each. The control was given concurrent chemotherapy and radiotherapy, while the observation was given Shashen Maidong decoction plus Sangju Yin. Results: The difference of gastrointestinal reactions and neutropenia between two groups was statistically significant (P〈0.05), in the contrary the difference of liver dysfunction between two groups has no statistically significant (P〉0.05). Conclusion:Shashen Maidong decoction plus Sangju Yin can reduce adverse reactions resulting from NSCLC chemo and radio therapy, improve resistance of chemotherapy.
关 键 词:沙参麦冬汤 桑菊饮 放化疗 非小细胞肺癌 不良反应
分 类 号:R322.35[医药卫生—人体解剖和组织胚胎学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222